Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Neurol Neurosurg Psychiatry. 2016 Apr 12;87(12):1303–1310. doi: 10.1136/jnnp-2015-312723

Table 1.

Participant demographics and MoCA performance

N Age M (SD) years Gender F/M Caucasian (%) Education M (SD) years MoCA score M(SD) (range 0–30) s-MoCA* score M(SD) (range 0–16)
All neurological diagnoses 1675 70.00 (10.15) 783/888 85 15.12 (3.37) 21 (7)   9 (4)
AD 354 75.96 (8.19) 228/126 71 13.71 (3.90) 14 (6)   5 (3)
MCI 117 73.50 (8.81)   59/58 79 14.95 (3.66) 21 (4)   9 (3)
PD 690 64.84 (9.68) 267/423 94 15.99 (2.65) 25 (4) 12 (3)
PD-dementia 91 70.66 (8.34)   27/63 92 15.50 (2.70) 21 (5)   9 (4)
HC 175 71.96 (9.34) 116/59 80 16.02 (2.71) 27 (2) 14 (2)

All significant pairwise comparisons p<0.01.

Age: HC>all neuro; HC<AD; HC>PD; AD>MCI; MCI=HC; PD<PDD.

Sex: HC≠all; HC=AD; AD≠MCI; MCI≠HC; PD≠HC; PD=PDD.

Race: HC=all neuro=MCI; AD≠HC; AD=MCI; PD≠HC; PD=PDD.

Education: HC>all neuro, AD, and MCI; HC=PD=PDD.

MoCA: HC>all neuro, AD, MCI, PD, and PDD; MCI>AD; PD>PDD.

s-MoCA: HC>all neuro, AD, MCI, PD, and PDD; MCI>AD; PD>PDD.

*

Maximum score=16.

All individuals with at least one neurological condition. 220 individuals had other neurological diagnoses (see figure 2); 107 individuals qualified for multiple clinical diagnoses; 96 individuals were not healthy, but had indeterminate diagnosis at the time of MoCA testing.

Dementia in PDD participants was determined either through a consensus process19 criteria for PDD, or was made by an experienced movement disorders neurologist.

AD, Alzheimer’s disease; F, female; HC, healthy control; M, male; MCI, mild cognitive impairment; MoCA, Montreal Cognitive Assessment; PD, Parkinson’s disease; PDD, PD with dementia; s-MoCA, short form MoCA.